SEC Company Response from ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550) (CLPT) — Oct 6, 2016
ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)
Date: Oct. 6, 2016 · CIK: 0001285550 · Accession: 0001534424-16-001080
AI Filing Summary & Sentiment
File numbers found in text: 333-213896
Show Raw Text
CORRESP
1
filename1.htm
October 6, 2016
VIA
EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
MRI Interventions, Inc.
Registration Statement on Form S-1
File No. 333-213896
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
In accordance with Rule
461 under the Securities Act of 1933, as amended, MRI Interventions, Inc. (the “Company”) hereby respectfully
requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1, File Number 333-213896, so
that it will be declared effective on October 11, 2016 at 9:01 a.m. Eastern Time, or as soon as practicable thereafter.
This letter will confirm
that the Company acknowledges that:
· should the Securities and Exchange Commission (the “Commission”)
or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking
any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy
of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the
United States.
Please contact our legal
counsel, Richard F. Mattern, of Bass, Berry & Sims PLC, at (901) 543-5933, if you have any questions concerning this request.
Sincerely,
MRI Interventions,
Inc.
By:
/s/ Harold A. Hurwitz
Name:
Harold A. Hurwitz
Title:
Chief Financial Officer and Secretary